SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-052366
Filing Date
2023-10-06
Accepted
2023-10-06 18:08:43
Documents
1
Period of Report
2023-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12629
  Complete submission text file 0001209191-23-052366.txt   14251
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HORIZON THERAPEUTICS PLC 70 ST. STEPHEN'S GREEN DUBLIN L2 D02 E2X4
Business Address
McIlvenny Patrick (Reporting) CIK: 0001952703 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35238 | Film No.: 231315142